Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy

Lupus Science and Medicine

Volumn 1, Issue 1, 2014, Pages

  Robinson, Angela Byun ^a   Tangpricha, Vin ^b   Yow, Eric ^c   Gurion, Reut ^a   Schanberg, Laura E ^d   McComsey, Grace A ^e   Ardoin, Stacy ^d   Dewitt, Esi Morgan ^d   Rabinovich, C Egla ^d   Ellis, Janet ^d   Mieszkalski, Kelly ^d   Wootton, Janet ^d   Chira, Peter ^f   Hsu, Joyce ^f   Lee, Tzielan ^f   Sandborg, Christy ^f   Perea, Jan ^f   Gottlieb, Beth ^g   Irigoyen, Patricia ^g   Luftig, Jennifer ^g   Siddiqi, Shaz ^g   Ni, Zhen ^g   Orlando, Marilynn ^g   Pagano, Eileen ^g   Eichenfield, Andrew ^h   Imundo, Lisa ^h   Levy, Deborah ^h   Kahn, Philip ^h   Batres, Candido ^h   Cabral, Digna ^h   Haines, Kathleen A ⁱ   Kimura, Yukiko ⁱ   Li, Suzanne C ⁱ   Weiss, Jennifer ⁱ   Riordan, Mary Ellen ⁱ   Vaidya, Beena ⁱ   Von Scheven, Emily ^j   Mietus Snyder, Michelle ^j   Silverman, Earl ^k   Ng, Lawrence ^k   Bowyer, Suzanne ^l   Ballinger, Susan ^l   Klausmeier, Thomas ^l   Hinchman, Debra ^l   Hudgins, Andrea ^l   Punaro, Marilynn ^m   Henry, Shirley ^m   Zhang, Shuzen ^m   Singer, Nora G ^e   Brooks, Elizabeth B ^e   Miner, Stacy ^e   Szabo, Nancy ^e   Scalzi, Lisabeth ^e   Sherry, David ⁿ   Dorfeld, Libby ⁿ   Wilson, Sarajane ⁿ   Tress, Jenna ⁿ   McCurdy, Deborah ^o   Hernandez, Tatiana ^o   Vitale, Jyotsna ^o   Klein Gitelman, Marisa ^p   Kress, Angela ^p   Lowe, Nicole ^p   Patel, Falguni ^p   Wallace, Carol ^q   Hamilton, Stephanie ^q   Silver, Richard ^r   Caldwell, Katie ^r   Kamen, Diane ^r   Wagner Weiner, Linda ^s   Puplava, Becky ^s   Lonchev, Atanas ^s   Higgins, Gloria ^t   Bacani, Monica ^t   Brunner, Hermine ^u   Rutherford, Cynthia ^u   Meyers Eaton, Jamie ^u   Nelson, Shannen ^u   Grom, Alexei ^u   Jung, Larry ^v   Conway, Teresa ^v   Frank, Lacey ^v   Kuss, Lori ^v   Soep, Jenny ^w   Senz, Hazel ^w   Reed, Ann ^x   Mason, Thomas ^x   Jaquith, Jane ^x   Paepke Tollefsrud, Diana E ^x   more..

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Northwell Health   (United States)

^h NEW YORK PRESBYTERIAN HOSPITAL   (United States)

ⁱ Hackensack University Medical Center   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k HOSPITAL FOR SICK CHILDREN   (Canada)

^l INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

ⁿ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^o UCLA MEDICAL CENTER   (United States)

^p CHILDREN'S MEMORIAL HOSPITAL   (United States)

^q SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^r MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^s UNIVERSITY OF CHICAGO   (United States)

^t NATIONWIDE CHILDREN S HOSPITAL   (United States)

^u CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^v CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^w UNIVERSITY OF COLORADO   (United States)

^x MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ATORVASTATIN;

ADOLESCENT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CHILD; CHILDHOOD DISEASE; FEMALE; FOLLOW UP; HUMAN; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATOLOGY DAMAGE INDEX; SERUM; SLEDAI; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 84930194157     PISSN: None     EISSN: 20538790     Source Type: Journal    
DOI: 10.1136/lupus-2014-000037     Document Type: Article

References (46)

1. Nossent J, Cikes N, Kiss E, et al. Current causes of death in systemic lupus erythematosus in Europe, 2000-2004: relation to disease activity and damage accrual. Lupus 2007;16:309-17.
2. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-15.
3. Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
4. Westerweel PE, Luyten RK, Hoomans HA, et al. Premature atherosclerotic cardiovascular disease in systemic lupus erythemarosus. Arthritis Rheum 2007;56:1384-96.
5. Kienrich K, Tomaschitz A, Verheyen N, et al. Vitamin D and cardiovascular disease. Nutrients 2013;5:3005-21.
6. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11.
7. DiRosa M, Malaguarnera G, DeGregorio C, et al. Immunomodulatory effects of vitamin D3 in human monocyte and macrophages. Cell Immunol 2012;280:36-43.
8. Ruiz-Irastorza G, Egurbide MV, Olivares N, et al. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology 2008;47:920-3.
9. Kamen DL, Cooper GS, Bouali H, et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmunity Rev 2006;5:114-17.
10. Wright TB, Shults J, Leonard MB, et al. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 2009;155:260-5.
11. Borba VZC, Vieira JGH, Kasamatsu T, et al. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporosis Int 2009;20:427-33.
12. Robinson AB, Thierry-Palmer M, Gibson KL, et al. Disease activity, proteinuria, and vitamin D status in children with systemic lupus erythematosus and juvenile dermatomyositis. J Pediatr 2012;160:297-302.
13. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008;4:80-90.
14. Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000;164:4443-51.
15. D'Ambrosio D, Cippitelli M, Cocciolo MG, et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998;101:252-62.
16. Chen S, Sims GP, Chen XX, et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007;179:1634-47.
17. Ronnblom L, Pascual V. The innate immune system in SLE: Type I interferons and dendritic cells. Lupus 2008;17:394-9.
18. Schanberg LE, Sandborg C, Barnhart HX, et al. Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Arthritis Rheum 2012;64:285-96.
19. Perez-Castrillon JL, Abad Manteca L, Vega G, et al. Vitamin D levels and lipid response to atorvastatin. Int J Endocrinol 2010;2010:320721.
20. Schwartz JB. Effects of vitamin D supplementation in atorvastatin-treated patients: A new drug interaction with an unexpected consequence. Clin Pharmacol Ther 2009;85:198-203.
21. Petri MA, Kiani AN, Post W, et al. Lupus Atherosclerosis Prevention Study (LAPS). Ann Rheum Dis 2011;70:760-5.
22. Lamotte C, Iliescu C, Libersa C, et al. Increased intima-media thickness of the carotid artery in childhood: A systematic review of observational studies. Eur J Pediatr 2011;170:719-29.
23. Robinson AB, Tangpricha V, Yow E, et al. Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy. Lupus Sci Med 2014;1:e000011.
24. Kumar J, Muntner P, Kaskel FJ, et al. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics 2009;124:e362-70.
25. Robinson AB, Tangpricha V, Yow E, et al. for the APPLE investigators. Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy. Lupus Sci Med 2014;1:e000011.
26. Kiani AN, Fang H, Magder LS, et al. Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus. Rheumatology 2013;52:2071-6.
27. Lee SS, Singh S, Magder LS, et al. Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus. Lupus 2008;17:114-23.
28. Mochizuki T, Aotsuka S, Satoh T. Clinical and laboratory features of lupus patients with complicating pulmonary disease. Respir Med 1999;93:95-101.
29. Moutsopoulos HM, Mavridis AK, Acritidis NC, et al. High C-reactive protein response in lupus polyarthritis. Clin Exp Rheumatol 1983;1:53-5.
30. Liou LB. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients. Clin Exp Rheumatol 2001;19:515-23.
31. Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-38.
32. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. NEJM 2000;342:836-43.
33. Ardoin SA, Schanberg LE, Sandborg CI, et al. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ann Rheum Dis 2014;73:557-66.
34. Lemire JM, Archer DC, Beck L, et al. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 1995;125(6 Suppl):1704S-8S.
35. Boonstra A, Barrat FJ, Crain C, et al. 1alpha,25-Dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001;167:4974-80.
36. Martinesi M, Bruni S, Stio M, et al. 1,25-Dihydroxyvitamin D3 inhibits tumor necrosis factor-alpha-induced adhesion molecule expression in endothelial cells. Cell Biol Int 2006;30:365-75.
37. Sigmund CD, Okuyama K, Ingelfinger J, et al. Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct. J Biol Chem 1990;265:19916-22.
38. O'Connell TD, Berry JE, Jarvis AK, et al. 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 1997;272(4 Pt 2):H1751-8.
39. Oh J, Weng S, Felton SK, et al. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009;120:687-98.
40. Lind L, Hanni A, Lithell H, et al. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995;8:894-901.
41. Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997;96:1755-60.
42. Targher G, Bertolini L, Padovani R, et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006;65:593-7.
43. Ross AC, Tangpricha V, Judd S, et al. Vitamin D is Linked to Carotid Intima-Media Thickness, Inflammation, and Immune Reconstitution in HIV-Infected Individuals. Antivir Ther 2011;16:555-63.
44. Scragg R, Jackson R, Holdaway IM, et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: A community-based study. Int J Epidemiol 1990;19:559-63.
45. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-9.
46. Baldassarre D, Hamsten A, Veglia F, et al. Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (Carotid Intima Media Thickness [IMT] and IMT-Progression as Predictors of Vascular Events in a High Risk European Population) study. J Am Coll Cardiol 2012;60:1489-99.